Matthew Richard Moore - Net Worth and Insider Trading

Matthew Richard Moore Net Worth

The estimated net worth of Matthew Richard Moore is at least $1 Million dollars as of 2024-11-13. Matthew Richard Moore is the SVP and Chief Business Officer of Arcutis Biotherapeutics Inc and owns about 145,505 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $1 Million. Details can be seen in Matthew Richard Moore's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Richard Moore has not made any transactions after 2024-05-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Matthew Richard Moore

To

Matthew Richard Moore Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Richard Moore owns 1 companies in total, including Arcutis Biotherapeutics Inc (ARQT) .

Click here to see the complete history of Matthew Richard Moore’s form 4 insider trades.

Insider Ownership Summary of Matthew Richard Moore

Ticker Comapny Transaction Date Type of Owner
ARQT Arcutis Biotherapeutics Inc 2024-05-02 SVP and Chief Business Officer

Matthew Richard Moore Latest Holdings Summary

Matthew Richard Moore currently owns a total of 1 stock. Matthew Richard Moore owns 145,505 shares of Arcutis Biotherapeutics Inc (ARQT) as of May 2, 2024, with a value of $1 Million.

Latest Holdings of Matthew Richard Moore

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARQT Arcutis Biotherapeutics Inc 2024-05-02 145,505 10.25 1,491,426

Holding Weightings of Matthew Richard Moore


Matthew Richard Moore Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew Richard Moore has made a total of 3 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 4,681 shares on May 2, 2024, which brought Matthew Richard Moore around $40,912.

Insider Trading History of Matthew Richard Moore

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew Richard Moore Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew Richard Moore Ownership Network

Ownership Network List of Matthew Richard Moore

No Data

Ownership Network Relation of Matthew Richard Moore

Insider Network Chart

Matthew Richard Moore Owned Company Details

What does Arcutis Biotherapeutics Inc do?

Who are the key executives at Arcutis Biotherapeutics Inc?

Matthew Richard Moore is the SVP and Chief Business Officer of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include director & President and CEO Todd Franklin Watanabe , See Remarks Patrick Burnett , and SVP and General Counsel Masaru Matsuda .

Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary

Over the past 18 months, Matthew Richard Moore made 2 insider transaction in Arcutis Biotherapeutics Inc (ARQT) with a net sale of 8,149. Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 119,269 shares made by Patrick Burnett , a net sale of 24,466 shares made by Masaru Matsuda , and a net sale of 60,000 shares made by Howard G. Welgus .

In summary, during the past 3 months, insiders sold 81,406 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 81,406 shares. During the past 18 months, 294,384 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 191,869 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcutis Biotherapeutics Inc Insider Transactions

No Available Data

Matthew Richard Moore Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Richard Moore. You might contact Matthew Richard Moore via mailing address: C/o Arcutis Biotherapeutics, Inc., 3027 Townsgate Road, Suite 300, Westlake Village Ca 91361.